Moreover, the PI3K pathway inhibitory elements such as PTEN are frequently lost in GCB-DLBCL [156], while BCR mutations also result in its constitutive activation [157], leading to MYC dysregulation in DLBCL. The gene discussed is PTEN; the disease is diffuse large B-cell lymphoma.